Jessica L F Teh[Author] - Search Results

Year	Number of Results
2012	1
2014	1
2015	1
2016	2
2018	5
2019	1
2020	3
2024	0

1

Glutamatergic signaling in cellular transformation.

Teh JL, Chen S. Teh JL, et al. Pigment Cell Melanoma Res. 2012 May;25(3):331-42. doi: 10.1111/j.1755-148X.2012.00983.x. Epub 2012 Feb 20. Pigment Cell Melanoma Res. 2012. PMID: 22273393 Review.

2

Arrested Developments: CDK4/6 Inhibitor Resistance and Alterations in the Tumor Immune Microenvironment.

Teh JLF, Aplin AE. Teh JLF, et al. Clin Cancer Res. 2019 Feb 1;25(3):921-927. doi: 10.1158/1078-0432.CCR-18-1967. Epub 2018 Oct 4. Clin Cancer Res. 2019. PMID: 30287548 Free PMC article. Review.

3

Playing the Melanoma Endgame.

Teh JLF, Aplin AE. Teh JLF, et al. Clin Cancer Res. 2018 Oct 1;24(19):4629-4630. doi: 10.1158/1078-0432.CCR-18-0989. Epub 2018 May 16. Clin Cancer Res. 2018. PMID: 29769205 Free PMC article.

4

Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal Melanoma.

Teh JLF, Purwin TJ, Han A, Chua V, Patel P, Baqai U, Liao C, Bechtel N, Sato T, Davies MA, Aguirre-Ghiso J, Aplin AE. Teh JLF, et al. Mol Cancer Ther. 2020 Aug;19(8):1719-1726. doi: 10.1158/1535-7163.MCT-19-1016. Epub 2020 May 19. Mol Cancer Ther. 2020. PMID: 32430489 Free PMC article.

5

Targeting PHGDH Upregulation Reduces Glutathione Levels and Resensitizes Resistant NRAS-Mutant Melanoma to MAPK Kinase Inhibition.

Nguyen MQ, Teh JLF, Purwin TJ, Chervoneva I, Davies MA, Nathanson KL, Cheng PF, Levesque MP, Dummer R, Aplin AE. Nguyen MQ, et al. Among authors: teh jlf. J Invest Dermatol. 2020 Nov;140(11):2242-2252.e7. doi: 10.1016/j.jid.2020.02.047. Epub 2020 May 7. J Invest Dermatol. 2020. PMID: 32389536 Free PMC article.

6

Activation of CD8⁺ T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors.

Teh JLF, Erkes DA, Cheng PF, Tiago M, Wilski NA, Field CO, Chervoneva I, Levesque MP, Xu X, Dummer R, Aplin AE. Teh JLF, et al. Cancer Immunol Res. 2020 Sep;8(9):1114-1121. doi: 10.1158/2326-6066.CIR-19-0743. Epub 2020 Jul 13. Cancer Immunol Res. 2020. PMID: 32661093 Free PMC article.

7

Frizzled with age: an opportunity for 'gerontological medicine'.

Teh JL. Teh JL. Pigment Cell Melanoma Res. 2016 Sep;29(5):488-9. doi: 10.1111/pcmr.12493. Epub 2016 Jun 30. Pigment Cell Melanoma Res. 2016. PMID: 27223582 No abstract available.

8

In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms.

Teh JLF, Cheng PF, Purwin TJ, Nikbakht N, Patel P, Chervoneva I, Ertel A, Fortina PM, Kleiber I, HooKim K, Davies MA, Kwong LN, Levesque MP, Dummer R, Aplin AE. Teh JLF, et al. Cancer Discov. 2018 May;8(5):568-581. doi: 10.1158/2159-8290.CD-17-0699. Epub 2018 Mar 1. Cancer Discov. 2018. PMID: 29496664 Free PMC article.

9

Metabotropic glutamate receptor 1 mediates melanocyte transformation via transactivation of insulin-like growth factor 1 receptor.

Teh JL, Shah R, Shin SS, Wen Y, Mehnert JM, Goydos J, Chen S. Teh JL, et al. Pigment Cell Melanoma Res. 2014 Jul;27(4):621-9. doi: 10.1111/pcmr.12237. Epub 2014 Apr 11. Pigment Cell Melanoma Res. 2014. PMID: 24628914 Free PMC article.

10

An In Vivo Reporter to Quantitatively and Temporally Analyze the Effects of CDK4/6 Inhibitor-Based Therapies in Melanoma.

Teh JL, Purwin TJ, Greenawalt EJ, Chervoneva I, Goldberg A, Davies MA, Aplin AE. Teh JL, et al. Cancer Res. 2016 Sep 15;76(18):5455-66. doi: 10.1158/0008-5472.CAN-15-3384. Epub 2016 Aug 3. Cancer Res. 2016. PMID: 27488531 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year